GSA Capital Partners LLP Purchases New Shares in LifeStance Health Group, Inc. (NASDAQ:LFST)

GSA Capital Partners LLP bought a new position in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 170,043 shares of the company's stock, valued at approximately $1,132,000.

Several other institutional investors and hedge funds also recently made changes to their positions in LFST. Vanguard Group Inc. raised its position in shares of LifeStance Health Group by 7.9% during the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company's stock worth $78,781,000 after acquiring an additional 784,818 shares during the last quarter. Jennison Associates LLC boosted its holdings in LifeStance Health Group by 2.1% in the first quarter. Jennison Associates LLC now owns 8,255,236 shares of the company's stock valued at $54,980,000 after acquiring an additional 168,856 shares during the last quarter. Wellington Management Group LLP boosted its holdings in LifeStance Health Group by 9.2% in the fourth quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company's stock valued at $38,886,000 after acquiring an additional 445,796 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in LifeStance Health Group by 87.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock valued at $25,977,000 after acquiring an additional 1,643,390 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in LifeStance Health Group by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company's stock valued at $25,546,000 after acquiring an additional 13,293 shares during the last quarter. Institutional investors and hedge funds own 85.50% of the company's stock.

LifeStance Health Group Trading Down 4.8%

LFST traded down $0.19 during trading on Friday, hitting $3.79. The company's stock had a trading volume of 2,008,460 shares, compared to its average volume of 2,317,990. LifeStance Health Group, Inc. has a twelve month low of $3.74 and a twelve month high of $8.61. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 0.19. The stock's fifty day moving average price is $4.96 and its 200-day moving average price is $6.34. The firm has a market capitalization of $1.47 billion, a P/E ratio of -37.90 and a beta of 1.14.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, insider Ujjwal Ramtekkar sold 16,000 shares of the business's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $5.94, for a total value of $95,040.00. Following the transaction, the insider directly owned 113,435 shares of the company's stock, valued at approximately $673,803.90. The trade was a 12.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 3.20% of the company's stock.

Analyst Ratings Changes

LFST has been the topic of several analyst reports. BTIG Research initiated coverage on LifeStance Health Group in a report on Friday, July 25th. They issued a "buy" rating and a $8.00 target price on the stock. KeyCorp initiated coverage on LifeStance Health Group in a report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 target price on the stock. Finally, UBS Group upgraded LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 target price on the stock in a report on Tuesday, May 27th. One analyst has rated the stock with a sell rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $8.42.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.